Verdence Capital Advisors LLC Quest Diagnostics Inc Transaction History

Verdence Capital Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$120.62 - $141.12 $19,419 - $22,720	161 Added 3.18%	5,223 $720,000
Q3 2023 Oct 25, 2023	BUY	$121.86 - $144.92 $61,173 - $72,749	502 Added 11.01%	5,062 $616,000
Q2 2023 Jul 28, 2023	SELL	$130.56 - $146.84 $64,496 - $72,538	-494 Reduced 9.77%	4,560 $640,000
Q1 2023 Apr 24, 2023	SELL	$131.53 - $155.76 $139,158 - $164,794	-1,058 Reduced 17.31%	5,054 $715,000
Q4 2022 Jan 20, 2023	SELL	$123.31 - $157.26 $162,769 - $207,583	-1,320 Reduced 17.76%	6,112 $0
Q3 2022 Nov 15, 2022	SELL	$121.77 - $141.1 $105,087 - $121,769	-863 Reduced 10.4%	7,432 $912,000
Q2 2022 Aug 08, 2022	SELL	$127.07 - $145.39 $78,529 - $89,851	-618 Reduced 6.93%	8,295 $1.1 Million
Q1 2022 May 02, 2022	BUY	$129.09 - $164.35 $536,110 - $682,545	4,153 Added 87.25%	8,913 $1.22 Million
Q4 2021 Jan 26, 2022	BUY	$140.36 - $173.01 $386,832 - $476,815	2,756 Added 137.52%	4,760 $824,000
Q3 2021 Nov 12, 2021	BUY	$132.95 - $158.0 $266,431 - $316,632	2,004 New	2,004 $291,000

933

93.8M

501K

238K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Verdence Capital Advisors LLC with notifications on news.